Description:

CQI is an ongoing, data driven approach to make incremental improvements to processes, patient safety, and outcomes. By implementing CQI methods, facilities can reduce preventable harm, improve efficiency and equity, and foster a just culture. Oftentimes, facilities that lack a just culture tend to have employees that shirk away from reporting medication errors in fear of punishment. However, there are many scenarios where the system can be improved. This cannot happen if nobody is reporting preventable medical errors.

Target Audience: 

Pharmacists (PharmD)

Learning Objectives:

At the completion of this activity, learners will be able to:Recall DKA treatment goals.

• Define Continuous Quality Improvement (CQI)
• Explain the importance of CQI in practice settings
• Identify and describe CQI methodologies, including PDSA, 5 Whys, and FMEA
• Apply a structured CQI methodology to current practice problem

Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:

Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:

Foster, A. A., Daly, C. J., Logan, T., Logan Jr, R., Jarvis, H., Croce, J., ... & Jacobs, D. M. (2021). Addressing social determinants of health in community pharmacy: innovative opportunities and practice models. Journal of the American Pharmacists Association, 61(5), e48-e54. LINK

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.   

Committee Member(s)

Jennifer Biltoft, PharmD, MHA, BCPS has no relevant financial relationships to disclose at this time.

Yu Christine Chan, B.S. Pharm, BCCCP, BCPS has no relevant financial relationships to disclose at this time.

Hyunah Eom, PharmD has no relevant financial relationships to disclose at this time.

Phipson Wu, PharmD, BCPS has no relevant financial relationships to disclose at this time.

Laura Zhang, Pharm. D. has no relevant financial relationships to disclose at this time.

Moderator(s)

Phipson Wu, PharmD, BCPS has no relevant financial relationships to disclose at this time.

Peer Reviewer(s)

Monica Awad, Monica Awad, PharmD, BCPPS has no relevant financial relationships to disclose at this time.

Planner(s)

Monica Awad, Monica Awad, PharmD, BCPPS has no relevant financial relationships to disclose at this time.

Jennifer Biltoft, PharmD, MHA, BCPS has no relevant financial relationships to disclose at this time.

Yu Christine Chan, B.S. Pharm, BCCCP, BCPS has no relevant financial relationships to disclose at this time.

Hyunah Eom, PharmD has no relevant financial relationships to disclose at this time.

Phipson Wu, PharmD, BCPS has no relevant financial relationships to disclose at this time.

Laura Zhang, Pharm. D. has no relevant financial relationships to disclose at this time.

– Provider Designee/Verification:  Fozia Ferozalai, Ed.D.